MDxHealth (MDXH) Enterprise Value (2020 - 2026)

MDxHealth has reported Enterprise Value for 8 years, with the latest figure at -$43.2 million in Q1 2026.

• Quarterly Enterprise Value rose 34.29% year-over-year to -$43.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$43.2 million (up 34.29% YoY) and the FY2025 annual result came in at -$47.3 million, changed 0.0% from the prior year.
• Enterprise Value eased to -$43.2 million in Q1 2026 per MDXH's latest filing, from -$29.5 million in the prior quarter.
• Over five years, Enterprise Value peaked at $20.7 million in Q4 2022 and troughed at -$65.7 million in Q1 2025.
• A 5-year average of -$28.3 million and a median of -$32.4 million in 2023 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2022 and 2024: Enterprise Value jumped 142.93% in 2022, then plunged 385.46% in 2024.
• Over 5 years, Enterprise Value stood at $20.7 million in 2022, then declined by 19.96% to $16.6 million in 2023, then slumped by 385.46% to -$47.3 million in 2024, then surged by 37.56% to -$29.5 million in 2025, then sank by 46.12% to -$43.2 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$43.2 million, -$29.5 million, and -$32.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.